Skip to main content
Jason Bradt, MD, Emergency Medicine, Cambridge, MA

JasonBradtMD, MBA, MHA

Emergency Medicine Cambridge, MA

Undersea & Hyperbaric Medicine

Chief Medical Officer, True North Equities

Dr. Bradt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bradt's full profile

Already have an account?

  • Office

    One Main Street
    suite 700
    Cambridge, MA 02142
    Phone+1 339-223-2098

Education & Training

  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumInternship, Transitional Year, 1998 - 1999
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1997

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1998 - 2025

Publications & Presentations

PubMed

Journal Articles

  • Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study  
    Elaine Kulm, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon6, Virgil A.S.H. Dalm, Julia Körholz, Vassilios Lougaris, Jo Luscombe &amp..., Future Rare Disease, 7/9/2024
  • Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome  
    V. Koneti Rao, Elaine Kulm, Jennifer Grossman, David Buchbinder, Hey Chong, Jason Bradt, Sharon Webster, Anna Šedivá, Virgil A. Dalm, Gulbu Uzel, Blood Advances, 6/25/2024
  • Long-Term Treatment With Selective PI3Kδ Inhibitor Leniolisib in Adults With Activated PI3Kδ Syndrome  
    V. Koneti Rao, Elaine M Kulm, Jennifer K Grossman, David K Buchbinder, Hey Chong, Jason Bradt, Sharon Webster, Anna Šedivá, Virgil A. Dalm, Gulbu Uzel, Blood Advances, 4/9/2024
  • Join now to see all

Abstracts/Posters

  • Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients w...
    V. Koneti Rao, Sharon Webster, Anna Sediva, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Virgil A.S.H. Dalm, Antonino Trizzino, Yulia Zharankova, El..., Blood, 11/15/2022
  • Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
    V. Koneti Rao*1, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schütz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil Dalm, Antonino Trizzino, Yulia..., 13th Annual Meeting of the Clinical Immunology Society, Charlotte, NC, 4/1/2022
  • Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
    V. Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schütz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil Dalm, Antonino Trizzino, Yulia Z..., Selected Abstracts from the 13th Annual Meeting of the Clinical Immunology Society: 2022 Annual Meeting: Immune Deficiency and Dysregulation North American Conference, Charlotte, North Carolina, 3/31/2022
  • Join now to see all

Press Mentions

  • Lundbeck to Present Data on Alzheimer’s, Epilepsy and Movement Disorder Medicines at AAN
    Lundbeck to Present Data on Alzheimer’s, Epilepsy and Movement Disorder Medicines at AANApril 11th, 2016
  • Death of Spy Who Ingested Polonium Spurs Drug Companies
    Death of Spy Who Ingested Polonium Spurs Drug CompaniesJanuary 25th, 2007
  • American Academy of Neurology and Lundbeck Offer New Clinical Research Training Fellowships in Epilepsy, Parkinson’s
    American Academy of Neurology and Lundbeck Offer New Clinical Research Training Fellowships in Epilepsy, Parkinson’sJune 6th, 2017